We looked at real-world data that assessed the association between recurrence-free survival and subsequent overall-survival. This is something that we have essentially assumed and with good reason, that if you have a relapse, you are likely to have a shorter survival, but these are data to speak to that. We also saw in really delving into the data that there are patients who have a risk of dying well beyond four and five years, times when you might think that if you’re still alive, you are completely in the clear...
We looked at real-world data that assessed the association between recurrence-free survival and subsequent overall-survival. This is something that we have essentially assumed and with good reason, that if you have a relapse, you are likely to have a shorter survival, but these are data to speak to that. We also saw in really delving into the data that there are patients who have a risk of dying well beyond four and five years, times when you might think that if you’re still alive, you are completely in the clear. Now in truth, a lot of the risk of dying beyond four or five years after surgery is from competing comorbidities, advancing age. This is a population that from the time of diagnosis at 70 or 72 or something you’re talking about now patients getting well into their 70s, but just that there is an ongoing drop off in survival. It is associated with a higher risk as if you have a relapse, but really that patients remain at risk of dying for many years after that.